Macrolane for Enhancement of the Shape and Fullness of the Female Breast
- Conditions
- Breast Enhancement
- Interventions
- Device: Macrolane
- Registration Number
- NCT01308853
- Lead Sponsor
- Galderma R&D
- Brief Summary
The study evaluates treatment procedure, efficacy and safety of Macrolane for female breast enhancement.
- Detailed Description
This study evaluates the injection technique and treatment outcome by stepwise inclusion and treatment of Macrolane for female breast enhancement.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 24
- Female between 25 and 50 years of age with small breasts seeking enhancement of the shape and fullness of the breast
- Unreasonable expectations
- Any medical condition that may interfere with the treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Macrolane Macrolane Open label
- Primary Outcome Measures
Name Time Method Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment 6 weeks Inclusion was made in steps in group of 4 subjects. The subjects were followed-up with MRI 1-5 days after the injection to document correct injection technique. Before the next group were treated, the Expert Group evaluated the 6-week follow-up results of the previous group. The injection procedure was, if necessary, changed in accordance with specifically pre-defined parameters.
- Secondary Outcome Measures
Name Time Method Percentage of Breasts With Improvement as Assessed by the Investigator 6 weeks Esthetic improvement was evaluated using the Global Esthetic Improvement Scale (GEIS).
The scale has five grades ranging from worse to very much improved. Subjects defined as "at least improved" are assessed as improved, much improved or very much improved.